Literatur
Jocham D, Witjes F, Wagner S et al. (2005) Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study. J Urol 174: 862–866
de Reijke TM, Kurth KH, Sylvester RJ et al. (2005) Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906). J Urol 173: 405–409
Kipp BR, Karnes RJ, Brankley SM et al. (2005) Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization. J Urol 173: 401–404
Dyrskjot L, Zieger K, Kruhoffer M et al. (2005) A molecular signature in superficial bladder carcinoma predicts clinical outcome. Clin Cancer Res 11: 4029–4036
Blaveri E, Simko JP, Korkola JE et al. (2005) Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Re 11: 4044–4055
Harisinghani MG, Barentsz J, Hahn PF et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 19:348: 2491–2499
Deserno WM, Harisinghani MG, Taupitz M et al. (2004) Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233: 449–456
Fleischmann A, Thalmann GN, Markwalder R, Studer UE (2005) Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol 23: 2358–2365
Kurahashi T, Hara I, Oka N et al. (2005) Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 11: 3773–3777
Retz MM, Sidhu SS, Blaveri E et al. (2005) CXCR4 expression reflects tumor progression and regulates motility of bladder cancer cells. Int J Cancer 114: 182–189
Retz M, Sidhu SS, Lehmann J et al. (2005) New HIV-drug inhibits in vitro bladder cancer migration and invasion. Eur Urol 48: 1025–1030
Advanced Bladder Cancer (ABC) meta-analysis collaboration (2005) Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 48: 202–205
Advanced Bladder Cancer (ABC) meta-analysis collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 48: 189–199
Lehmann J, Retz M, Wiemers C et al. (2005) Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol 23: 4963–4974
Gschwend JE, Volkmer BG, Hautmann RE (2004) Radical cystectomy for bladder cancer in the neobladder era – progression and survival in 674 consecutive patients. J Urol 171: 304A
Author information
Authors and Affiliations
Corresponding author
Additional information
* Präsentation im Rahmen des Schlussforums der Jahrestagung der Deutschen Gesellschaft für Urologie, Düsseldorf 2005
Rights and permissions
About this article
Cite this article
Gschwend, J. Was gibt’s Neues beim Harnblasenkarzinom*. Urologe 45, 496–498 (2006). https://doi.org/10.1007/s00120-006-1040-8
Issue Date:
DOI: https://doi.org/10.1007/s00120-006-1040-8